Lipid management: Tools for getting to the goal

American Journal of Managed Care

Volumn 7, Issue 9 SUPPL., 2001, Pages

  McKenney, J M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BILE ACID; CERIVASTATIN; COLESEVELEM; COLESTIPOL; COLESTYRAMINE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; RESIN; SATURATED FATTY ACID; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CLINICAL TRIAL; CONFERENCE PAPER; DIET RESTRICTION; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HEALTH CARE MANAGEMENT; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID ANALYSIS; LIVER DISEASE; LIVER TOXICITY; MYOSITIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SKIN DISEASE; TREATMENT OUTCOME; UNITED STATES; WEIGHT REDUCTION;

ANTICHOLESTEREMIC AGENTS; BILE ACIDS AND SALTS; CHOLESTEROL; DRUG THERAPY, COMBINATION; HUMANS; HYPERCHOLESTEROLEMIA; LIFE STYLE; NIACIN; PRACTICE GUIDELINES; SIMVASTATIN; UNITED STATES;

EID: 0034866496     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
3. Hypertriglyceridemia as a cardiovascular risk factor
4. Joint effects of serum triglyceride and LDL-C and HDL-C concentrations on coronary heart disease risk in the Helsinki Heart Study: Implications for treatment
5. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol
6. Lipoprotein lipid response to the National Cholesterol Education Program step II diet by hypercholesterolemic and combined hyperlipidemic women and men
7. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study
8. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: The DELTA Study
9. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study
10. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico
11. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Aterosclerosis Prevention Study
12. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
13. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
14. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
15. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators
16. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
17. Colesevelam hydrochloride (Cholestagel): A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects
18. Drug treatment of lipid disorders
19. Coronary drug project: Experience with niacin. Coronary Drug Project Research Group
20. Efficacy and safety of combined simvastatin and colesevelam in patients with primary hypercholesterolemia
21. Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia
22. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin
23. Pravastatin reduces major coronary events in patients with low levels of both high-density lipoprotein cholesterol and low-density lipoprotein cholesterol: Results from the LIPID study